Roche Holding AG (SWX:ROG)
265.20
-5.90 (-2.18%)
Sep 23, 2025, 5:31 PM CET
Roche Holding AG Revenue
Roche Holding AG had revenue of 31.85B CHF in the half year ending June 30, 2025, with 4.03% growth. This brings the company's revenue in the last twelve months to 63.49B, up 4.80% year-over-year. In the year 2024, Roche Holding AG had annual revenue of 62.40B with 3.23% growth.
Revenue (ttm)
63.49B
Revenue Growth
+4.80%
P/S Ratio
3.58
Revenue / Employee
614.90K
Employees
103,249
Market Cap
227.53B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 62.40B | 1.95B | 3.23% |
Dec 31, 2023 | 60.44B | -5.37B | -8.16% |
Dec 31, 2022 | 65.81B | -36.00M | -0.05% |
Dec 31, 2021 | 65.85B | 5.51B | 9.13% |
Dec 31, 2020 | 60.34B | -3.41B | -5.35% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novartis AG | 43.89B |
Lonza Group AG | 7.09B |
Galderma Group AG | 3.73B |
Alcon | 7.97B |
Sandoz Group AG | 8.42B |
Straumann Holding AG | 2.58B |
Sonova Holding AG | 3.87B |
Ypsomed Holding AG | 748.87M |
Roche Holding AG News
- 19 hours ago - Roche's Giredestrant: A Ray Of Hope On A Cloudy Horizon? - Seeking Alpha
- 1 day ago - Roche Holding AG - Special Call - Seeking Alpha
- 1 day ago - Roche Targets Top Spot In Weight Loss Drug Market - Benzinga
- 1 day ago - Roche Targets Top Spot In Weight Loss Drug Market - Benzinga
- 1 day ago - Roche (RHHBY) Reports Positive Trial Results for Breast Cancer Drug Portfolio - GuruFocus
- 1 day ago - Roche moves obesity asset CT-388 into phase 3 - Seeking Alpha
- 1 day ago - Roche CEO, pharma execs to meet with Swiss government over US tariffs - Reuters
- 1 day ago - Roche (RHHBY) Shares Rise on Positive Trial Results for Breast Cancer Drug - GuruFocus